Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24991787 | 0.86 | CYP2D6 (0.32) | — | |
| SCHEMBL17531005 | 0.86 | — | — | |
| SCHEMBL17531006 | 0.86 | — | — | |
| SCHEMBL252442 | 0.79 | — | — | |
| SCHEMBL19546030 | 0.76 | — | — | |
| SCHEMBL13571386 | 0.73 | — | — | |
| SCHEMBL31602089 | 0.73 | — | — | |
| SCHEMBL6340903 | 0.73 | — | — | |
| SCHEMBL6338522 | 0.73 | — | — | |
| SCHEMBL31042221 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4674855-A1 | A COMPOUND, AN ORGANIC LIGHT EMITTING DIODE COMPRISING THE DERIVATES, A USE OF THE DIODE, AND A CONSUMER PRODUCT | Noctiluca S.A. (PL) | 2026-01-07 | — | — | EP | disclosed |
| EP-4592297-A1 | AN ORGANIC BORON COMPOUND, AN ORGANIC LIGHT EMITTING DIODE COMPRISING THE ORGANIC BORON COMPOUND, A USE OF THE DIODE, AND A CONSUMER PRODUCT | Noctiluca S.A. (PL) | 2025-07-30 | — | — | EP | disclosed |
| CN-114829452-A | Immobilization of phenolic compounds | 斯帕果纳米医学有限公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-104289208-A | Preparation method of full-porous spherical silica gel bonded by liquid crystal polymer | CHINA PETROLEUM & CHEMICAL | 2015-01-21 | — | — | CN | disclosed |
| US-7488372-B2 | Process for inhibiting deposition of solids from a gaseous stream | SHELL OIL COMPANY (US) | 2009-02-10 | — | — | US | disclosed |
| EP-1843997-B1 | TREATMENT OF AN AQUEOUS MIXTURE CONTAINING AN ALKYLENE OXIDE WITH AN ION EXCHANGE RESIN | SHELL INT RESEARCH (NL) | 2008-09-03 | — | — | EP | disclosed |
| CN-100390143-C | Synthesis of oxygen-substituted benzocycloheptenes, used as valuable intermediate products for producing tissue-selective oestrogens | SCHERING AG (DE) | 2008-05-28 | — | — | CN | disclosed |
| EP-1846141-B1 | PROCESS FOR INHIBITING DEPOSITION OF SOLIDS FROM A GASEOUS STREAM OBTAINED FROM A HYDROFORMYLATION REACTION MIXTURE | SHELL INT RESEARCH (NL) | 2008-05-07 | — | — | EP | disclosed |
| EP-1846141-A2 | PROCESS FOR INHIBITING DEPOSITION OF SOLIDS FROM A GASEOUS STREAM OBTAINED FROM A HYDROFORMYLATION REACTION MIXTURE | Shell Internationale Research Maatschappij B.V. (NL) | 2007-10-24 | — | — | EP | disclosed |
| EP-1843997-A1 | TREATMENT OF AN AQUEOUS MIXTURE CONTAINING AN ALKYLENE OXIDE WITH AN ION EXCHANGE RESIN | Shell Internationale Research Maatschappij B.V. (NL) | 2007-10-17 | — | — | EP | disclosed |
| US-20060189831-A1 | Process for inhibiting deposition of solids from a gaseous stream | SHELL OIL COMPANY | 2006-08-24 | — | — | US | disclosed |
| US-20060189833-A1 | Treatment of an aqueous mixture containing an alkylene oxide with an ion exchange resin | SHELL OIL COMPANY | 2006-08-24 | — | — | US | disclosed |
| WO-2006083942-A2 | PROCESS FIR INHIBITING DEPOSITION OF SOLIDS FROM A GASEOUS STREAM OBTAINED FROM A HYDROFORMYLATION REACTION MIXTURE | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2006-08-10 | — | — | WO | disclosed |
| WO-2006083896-A1 | TREATMENT OF AN AQUEOUS MIXTURE CONTAINING AN ALKYLENE OXIDE WITH AN ION EXCHANGE RESIN | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2006-08-10 | — | — | WO | disclosed |
| EP-1523556-A1 | METHODS OF TREATING CONDITIONS ASSOCIATED WITH AN EDG-1 RECEPTOR | SRI INTERNATIONAL (US) | 2005-04-20 | — | — | EP | disclosed |
| CN-1602298-A | Synthesis of oxygen-substituted benzocycloheptenes, used as valuable intermediate products for producing tissue-selective oestrogens | SCHERING AG (DE) | 2005-03-30 | — | — | CN | disclosed |
| US-20040147562-A1 | Methods of treating conditions associated with an EDG-1 receptor | MANIV ENERGY CAPITAL | 2004-07-29 | — | — | US | disclosed |
| WO-2004009816-A1 | METHODS OF TREATING CONDITIONS ASSOCIATED WITH AN EDG-1 RECEPTOR | CERETEK LLC (US) | 2004-01-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040147562-A1 | Methods of treating conditions associated with an EDG-1 receptor | EDNRA, EDNRB, ESRRG | ALDH1A1 1772/4885TSHR 388/4885TDP1 1159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.